RadNet Inc. (NASDAQ:RDNT) EVP Michael N. Murdock sold 38,333 shares of the business’s stock in a transaction dated Wednesday, March 14th. The shares were sold at an average price of $13.06, for a total value of $500,628.98. Following the sale, the executive vice president now directly owns 107,242 shares of the company’s stock, valued at approximately $1,400,580.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of RadNet Inc. (NASDAQ:RDNT) traded up $0.30 during midday trading on Wednesday, hitting $12.95. The stock had a trading volume of 697,861 shares, compared to its average volume of 202,552. RadNet Inc. has a 52 week low of $5.30 and a 52 week high of $13.40. The company has a debt-to-equity ratio of 7.88, a current ratio of 1.29 and a quick ratio of 1.29. The stock has a market capitalization of $616.73, a P/E ratio of 56.30, a price-to-earnings-growth ratio of 2.67 and a beta of 0.69.
RadNet (NASDAQ:RDNT) last issued its earnings results on Thursday, March 8th. The medical research company reported $0.13 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.14 by ($0.01). RadNet had a return on equity of 26.66% and a net margin of 0.01%. The company had revenue of $235.50 million during the quarter, compared to analysts’ expectations of $228.46 million. During the same period in the previous year, the company earned $0.08 EPS. RadNet’s quarterly revenue was up 4.7% on a year-over-year basis. sell-side analysts expect that RadNet Inc. will post 0.58 earnings per share for the current fiscal year.
RDNT has been the subject of a number of research reports. BidaskClub raised RadNet from a “hold” rating to a “buy” rating in a research report on Wednesday. Jefferies Group set a $14.00 price target on RadNet and gave the company a “buy” rating in a research report on Thursday, March 8th. Zacks Investment Research raised RadNet from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a research report on Thursday, January 4th. Raymond James Financial began coverage on RadNet in a research report on Wednesday. They issued a “strong-buy” rating and a $15.00 target price for the company. Finally, FIX began coverage on RadNet in a research report on Wednesday. They issued a “strong-buy” rating and a $15.00 target price for the company. One analyst has rated the stock with a hold rating, two have given a buy rating and two have issued a strong buy rating to the stock. The company has an average rating of “Buy” and an average price target of $13.75.
WARNING: This report was first reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was stolen and republished in violation of United States & international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2018/03/14/michael-n-murdock-sells-38333-shares-of-radnet-inc-rdnt-stock.html.
RadNet Company Profile
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.